09/09/2019 - 10:39

PharmAust fires up Phase II cancer trials

09/09/2019 - 10:39

Bookmark

Save articles for future reference.

PharmAust has kicked-off its much-anticipated Phase II clinical trials that will study the effectiveness of the new palatable and high dose tablet formulation of its Monepantel anti-cancer drug in dogs. The trial will determine the efficacy of the drug over a prolonged period of time in dogs with B cell lymphoma before testing progresses to low dose maintenance of progression free survival and efficacy in other cancers.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options